Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
GeneTether Therapeutics, Inc. (TSE:RIZE)
:RIZE
RIZE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.15
Previous CloseN/A
VolumeN/A
Average Volume (3M)4.32K
Market Cap
C$4.11M
Enterprise Value-C$791.40K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.67
Next Earnings
Apr 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding34,250,840
10 Day Avg. Volume2,450
30 Day Avg. Volume4,323
Standard Deviation0.76
R-Squared0.02
Alpha0.12
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-11.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
RIZE FAQ
What was GeneTether Therapeutics, Inc.’s price range in the past 12 months?
GeneTether Therapeutics, Inc. lowest stock price was C$0.01 and its highest was C$0.15 in the past 12 months.
What is GeneTether Therapeutics, Inc.’s market cap?
GeneTether Therapeutics, Inc.’s market cap is C$4.11M.
When is GeneTether Therapeutics, Inc.’s upcoming earnings report date?
GeneTether Therapeutics, Inc.’s upcoming earnings report date is Apr 24, 2025 which is in 62 days.
How were GeneTether Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is GeneTether Therapeutics, Inc. overvalued?
According to Wall Street analysts GeneTether Therapeutics, Inc.’s price is currently Overvalued.
Does GeneTether Therapeutics, Inc. pay dividends?
GeneTether Therapeutics, Inc. does not currently pay dividends.
What is GeneTether Therapeutics, Inc.’s EPS estimate?
GeneTether Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GeneTether Therapeutics, Inc. have?
GeneTether Therapeutics, Inc. has 34,250,840 shares outstanding.
What happened to GeneTether Therapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of GeneTether Therapeutics, Inc.?
Currently, no hedge funds are holding shares in TSE:RIZE
---
Company Description
GeneTether Therapeutics, Inc.
GeneTether Therapeutics Inc is an innovative genetic medicines company. It is engaged in creating best in class gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin.
---
Technical Analysis
---